Comparative Effectiveness of Individual Versus Group-Level Interventions to Increase PrEP Uptake and Reduce HIV/STI Incidence
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bisola O. Ojikutu, MD, MPH
Brigham and Women's Hospital
Principal Investigator - Gray M. Maganga, MS
Brigham and Women's Hospital
Study Director - Khady Diouf, MD
Brigham and Women's Hospital
Study Chair - Laura Bogart, PhD
RAND Corporation Inc
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Whittier Street Health Center
Roxbury, Massachusetts, United States
- Muslim Women'S Insitute for Research and Development
The Bronx, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Nov 2023
- Primary completion
- 26 Jan 2026
- Completion
- 26 Jan 2026
- Last update posted
- 27 Feb 2026
- Registered enrollment
- 149
- Registry id
- NCT06022809
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.